Tencent-backed medical diagnostics technology developer VoxelCloud has now raised $78.5m in total, Shenzhen Hongtai Capital Management having led its latest round.

Comcast Ventures is among the series A investors that returned to take part in the AI-based diagnostics software startup's series B round, bringing its overall funding to $37.5m.

Biosimilar developer Alvotech has received $50m from Fuji Pharma through a development and commercialisation deal, valuing it at $1.19bn.

Ikove Venture Partners has launched a $10m venture capital vehicle to help spawn spinouts based on projects at Ohio universities.

The cancer cell therapy developer and medical services provider has closed a $134m round co-led by China Pacific and Haier Capital along with China Industrial Asset Management.

The drug developer has received the convertible note financing from Eli Lilly as part of a licence and collaboration deal that could reach $190m.

Pharma CVCs have achieved an impressive exit record on the back of successes balancing tools in the innovation toolkit over the past 20 years

To mark JJDC’s 45th anniversary, GCV spoke to Asish Xavier and Renee Ryan, both vice-presidents for venture investments, who focus on biotech and medical devices respectively, and Stacy Feld, vice-president of consumer venture investments and external innovation.

Boston Scientific was among the participants in the urological cancer device developer's first funding round, as it prepares for US trials late next year.

Parkwalk Advisors has invested an undisclosed sum in Cardiff ultrasound simulation technology developer MedaPhor through its Opportunities Fund.